Exploring the toxicity and clinical outcomes of doxorubicin, cyclophosphamide, and taxane-based chemotherapies in women with breast cancer in Bangladesh
Journal of Oncology Pharmacy Practice
Published online on October 03, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
BackgroundIndividuals receiving chemotherapy for breast cancer frequently experience severe drug reactions, which exacerbates safety issues such as decreased quality of life, prolonged treatment, and reinforcement of negative emotions associated with ...
BackgroundIndividuals receiving chemotherapy for breast cancer frequently experience severe drug reactions, which exacerbates safety issues such as decreased quality of life, prolonged treatment, and reinforcement of negative emotions associated with ...